December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Volastra Therapeutics dosed the first patient in their Phase I/II clinical trial of VLS-1488
Nov 3, 2023, 12:06

Volastra Therapeutics dosed the first patient in their Phase I/II clinical trial of VLS-1488

Volastra Therapeutics shared on their LinkedIn page:

”We’ve dosed the first patient in our Phase I/II clinical trial of VLS-1488, our internally discovered KIF18A inhibiting drug designed to treat patients with advanced cancers characterized by high levels of chromosomal instability.”

For more information click here.
Source: Volastra Therapeutics/LinkedIn